ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
ALNYLAM PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$233.29+1.46 (+0.63%)
Close on Oct 19, 2026
- Market cap
- $32.26B
- P/E (TTM)
- 100.1
- Dividend yield
- –
Dividends
Alnylam Pharmaceuticals has not reported a dividend
No dividend per share appears in Alnylam Pharmaceuticals's annual filings since fiscal 2010.